Our study demonstrates that ROT down-regulates Sirt1 expression, which is in agreement with Tao et al. (2020) who showed that Sirt1 levels were decreased in ROT-treated animals and in vitro models of PD. The gene discussed is SIRT1; the disease is Parkinson disease.